Landscapes / Companies

Celldex Therapeutics not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 3
Next date
CDX-622, Phase 1 trial completes
Drugs
2
in active trials · 7 in all
Trials
7 active
19 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Phase 3 Jun 2028Phase 3 trial completes
—
Phase 1 Mar 2027Phase 1 trial completes

About

No active trial
CDX-1140, CDX-301, CDX-3379, CDX-527, CDX-585
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Celldex Therapeutics

Following is part of Solo: you see every change to Celldex Therapeutics the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in